mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases

In the prevention and treatment of infectious diseases, mRNA vaccines hold great promise because of their low risk of insertional mutagenesis, high potency, accelerated development cycles, and potential for low-cost manufacture. In past years, several mRNA vaccines have entered clinical trials and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Ting, Sun, Chao, Chang, Jitao, Zhang, Guijie, Yin, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877136/
https://www.ncbi.nlm.nih.gov/pubmed/35215994
http://dx.doi.org/10.3390/v14020401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877136/
https://www.ncbi.nlm.nih.gov/pubmed/35215994
http://dx.doi.org/10.3390/v14020401

Ejemplares similares